Name | 1-[4-(3-Fluoro-4-hydroxyphenyl)-1-piperazinyl]ethanone |
---|---|
Synonyms |
PKI 402
pound not PKI402 pound not PKI 402 1-[4-(3-ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]-3-{4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}urea 1-[4-(3-fluoro-4-hydroxy-phenyl)-piperazin-1-yl]-ethanone |
Molecular Formula | C12H15FN2O2 |
---|---|
Molecular Weight | 238.25800 |
Exact Mass | 238.11200 |
PSA | 43.78000 |
LogP | 1.20270 |
~% 742067-12-5 |
Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2004/69256 A1, 2004 ; Location in patent: Page/Page column 33 ; WO 2004/069256 A1 |
Precursor 1 | |
---|---|
DownStream 0 |